PBH

#1604
Prestige Consumer Healthcare Inc. Common Stock
47.5 1 USD
-1.98%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
47.22
47.84
Jahresspanne
42.74
87.12
Tagesänderung
-1.98%
Monatliche Änderung
-15.01%
6 month change
-20.70%
Jahresänderung
-43.54%
Vorheriger Schlusskurs
48.4 7
Open
47.7 6
Tief
47.2 2
High
47.8 4
Volumen
592
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 2.25 B
  • Employee 600
  • Founded 1996
  • CEO Matthew M. Mannelly
  • Website www.prestigebrands.com
  • Headquarter New York, United States
  • FIGI BBG000QM0RZ4
  • Industry Arzneimittelhersteller – spezialisierte und Generika
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
15.16
Preis-Umsatz-Verhältnis
2.79

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia. Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano. The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.

Nachrichten